Date post: | 28-Dec-2015 |
Category: |
Documents |
Upload: | george-york |
View: | 215 times |
Download: | 0 times |
Study flow diagramBB=blockers; HTN=hypertension; RCT=randomized controlled trial
Bangalore S. et al. Am J Cardiol. 2007;100:1254-62
Clinical trials comparing ß-blockers with placebo or diuretics
Bangalore S. et al. Am J Cardiol. 2007;100:1254-62
Bangalore S. et al. Am J Cardiol. 2007;100:1254-62
Blood pressure response: ß-blockers versus placebo or diuretics
Bangalore S. et al. Am J Cardiol. 2007;100:1254-62
Clinical trials comparing ß-blockers with nondiuretic antihypertensive agents
Bangalore S. et al. Am J Cardiol. 2007;100:1254-62
Blood pressure response: ß-blockers versus nondiuretic antihypertensive agents
Bangalore S. et al. Am J Cardiol. 2007;100:1254-62
Effect of ß-blockers on the risk for new-onset DM when compared to nondiuretic antihypertensive agents (CCBs, ACE inhibitors [ACEi], and ARBs)
Bangalore S. et al. Am J Cardiol. 2007;100:1254-62
Effect of different ß-blocker types on the risk for new-onset DM compared with other agents
Bangalore S. et al. Am J Cardiol. 2007;100:1254-62
Meta-regression analysis
Bangalore S. et al. Am J Cardiol. 2007;100:1254-62
RR for new-onset DM (NODM) as a function of systolic blood pressure (SBP) difference between
ß-blockers and nondiuretic antihypertensive agents
Bangalore S. et al. Am J Cardiol. 2007;100:1254-62
RR for new-onset DM as a function of baseline fasting blood glucose levels
Bangalore S. et al. Am J Cardiol. 2007;100:1254-62
RR for new-onset DM as a function of baseline BMI
Bangalore S. et al. Am J Cardiol. 2007;100:1254-62
RR for new-onset DM as a function of length of follow-up
Bangalore S. et al. Am J Cardiol. 2007;100:1254-62
ß-blockers for primary hypertension: pathogenesis for increased risk. BP=blood pressure SM=smooth muscle